Stocks · News reference

Why Is Biohaven Stock Soaring Wednesday?

Aug 26, 2026, 5:41 PMVandana Singh

Biohaven gains $795M in global licensing deal and $4M lawsuit win. BHVN jumps 13% as William Blair eyes upcoming trial data.

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 26, 2026, 5:41 PM
Checked: Aug 26, 2026, 5:41 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 26, 2026, 2:50 PMBenzinga Newsdesk
Biohaven shares are trading higher after the company announced that the U.S. District Court for the District of Delaware ruled in its favor in the case against Avilar Therapeutics. Biohaven announced a collaboration agreement under which SK Biopharmaceuticals will obtain an exclusive worldwide license to the company's Kv7 ion channel platform.
Read original at benzinga
BHVN
SEC EDGARAug 26, 2026, 10:38 AMSEC EDGAR
8-K filing — Biohaven Ltd. (BHVN)
Filed: 2026-08-26 AccNo: 0001935979-26-000072 Size: 890 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgar
BHVN
BenzingaAug 26, 2026, 9:22 AMAvi Kapoor
Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
JOYY Inc (NASDAQ: JOYY) reported Q2 earnings below estimates, but beat revenue expectations. Shares rise 3.6% in pre-market trading.
Read original at benzinga
ADBT AIXI AKAN BDRX BHVN